{"SPADE_N_06099": {"Clinical Information": [], "Patent Information": [{"Patent No": "US 2023/0416797 A1", "Patent Link": "http://www.lens.org/lens/patent/US_2023_0416797_A1", "Patent Type": "Patent Application", "Publication Date": "2023-12-28", "Family Info": "JP2023548477A,EP4243844A1,CN116685204A,WO2022104321A1", "Patent Title": "MODULATING ANTIMICROBIAL PEPTIDE HALF-LIFE", "Abstract": "Methods of modulating the half-life of an antimicrobial peptide are described. The method may include administering an antimicrobial peptide to an environment where the antimicrobial peptide remains active until a specified endpoint, and on or after the specified endpoint, digesting the antimicrobial peptide with a protease to thereby inactivate the antimicrobial peptide and modulate its half-life. Compositions and kits for modulating the half-life of an antimicrobial peptide are also described."}], "Sequence Information": {"SPADE ID": "SPADE_N_06099", "Sequence": "MFLVNQLGISKSLANTILGAIAVGNLASWLLALVPGPGWATKAALATAETIVKHEGKAAAIAW", "Sequence Length": 63, "Peptide Name": "Sequence 81 from US 20230416797", "Source": "Leuconostoc mesenteroides", "Biological Activity": ["Antimicrobial"], "Frequent Amino Acids": "ALG", "Absent Amino Acids": "CDORUY", "Basic Residues": 5, "Acidic Residues": 2, "Hydrophobic Residues": 39, "Polar Residues": 34, "Positive Residues": 5, "Negative Residues": 2, "Mass": 6411.52, "PI": 9.52, "Net Charge": 3, "Hydrophobicity": 0.8, "Similar Sequences": [{"SPADE_ID": "SPADE_N_09798", "Similarity": 1.0, "Sequence": "LVNQLGISKSLANTILGAIAVGNLASWLLALVPGPGWATKAALATAETIVKHEGKAAAIAW"}, {"SPADE_ID": "SPADE_N_00142", "Similarity": 0.9836065573770492, "Sequence": "LVNQLGISKSLANTILGAIAVGNLASWVLALVPGPGWATKAALATAETIVKHEGKAAAIAW"}, {"SPADE_ID": "SPADE_N_15838", "Similarity": 0.7213114754098361, "Sequence": "LIDHLGAPRWAVDTILGAIAVGNLASWVLALVPGPGWAVKAGLATAAAIVKHQGKAAAAAW"}]}}}